Common use of Technology Transfer Clause in Contracts

Technology Transfer. At Pfizer’s request, Licensee shall make available to Pfizer all currently available records and data which exist and are Controlled by Licensee as of the effective date of termination and are necessary or reasonably useful for Pfizer to continue using, Developing, Commercializing and Manufacturing the Products.

Technology Transfer. At Pfizer’s request, Licensee shall make available to Pfizer all currently available records and data which exist and are Controlled by Licensee as of the effective date of termination and are necessary or reasonably useful for Pfizer to continue using, Developing, Commercializing and Manufacturing the ProductsProduct.

Technology Transfer. At Pfizer’s request, Licensee shall make available to Pfizer all currently available records and data which exist and are Controlled by Licensee as of the effective date of termination and are necessary or reasonably useful for Pfizer to continue using, Developing, Commercializing and Manufacturing the Compounds and Products.

Technology Transfer. At PfizerLicensee’s request, Licensee Pfizer shall make available to Pfizer Licensee all currently available records and data which exist and are Controlled by Licensee Pfizer with respect to such Terminated Territory, as of the effective date of termination and are necessary or reasonably useful for Pfizer Licensee to continue using, Developing, Commercializing and Manufacturing Exploiting the ProductsProducts in such Terminated Territory.

Technology Transfer. At Pfizer’s request, Licensee shall make available to Pfizer all currently available records and data which exist and are Controlled by Licensee that exist as of the effective date of termination that are related to the Development, Manufacture or Commercialization of a Compound or Product, and that are necessary or reasonably useful for Pfizer to continue using, Developing, Commercializing and Manufacturing the ProductsProduct.

Technology Transfer. At Pfizer’s request, Licensee shall make available to Pfizer all currently available records and data which exist and are Controlled by Licensee with respect to such Terminated Product, Terminated Target or Terminated Territory, as applicable, as of the effective date Table of termination Contents of termination, and are necessary or reasonably useful for Pfizer to continue using, Developing, Commercializing and Manufacturing the Productswith respect to such Terminated Product, Terminated Target or Terminated Territory, as applicable.

Technology Transfer. At Pfizer’s request, Licensee shall make available to Pfizer all currently available records and data which exist and are Controlled by Licensee as of the effective date of termination and are necessary or reasonably useful for Pfizer to continue using, Developing, Commercializing Exploiting the TL1A Antibody and Manufacturing Products in the ProductsField in the Territory.

Technology Transfer. At Pfizer’s request, Licensee shall make available to Pfizer all currently available records and data which exist and are Controlled by Licensee with respect to such Terminated Territory, as of the effective date of termination termination, and are necessary or reasonably useful for Pfizer to continue using, Developing, Commercializing and Manufacturing Exploiting the ProductsProducts in such Terminated Territory.

Technology Transfer. At PfizerLicensee’s request, Licensee Pfizer shall make available to Pfizer Licensee all currently available records and data which exist and are Controlled by Licensee Pfizer as of the effective date of termination and are necessary or reasonably useful for Pfizer Licensee to continue using, Developing, Commercializing and Manufacturing Exploiting the ProductsTL1A Antibody and Products in the Field in the Territory.

Technology Transfer. At Pfizer’s request, Licensee shall make available to Pfizer all currently available records and data which exist and are Controlled by Licensee as of the effective date of termination termination, are solely related to the Product, and are necessary or reasonably useful for Pfizer to continue using, Developing, Commercializing and Manufacturing the ProductsProduct as it exists or is contemplated to exist as of the effective date of termination.

Technology Transfer. At Pfizer’s request, Licensee shall make available to Pfizer all currently available records and data which exist and are Controlled by Licensee with respect to the Terminated Territory as of the effective date of termination termination, are solely related to the Product, and are necessary or reasonably useful for Pfizer to continue using, Developing, Commercializing and Manufacturing the ProductsProduct as it exists or is contemplated to exist as of the effective date of termination in the Terminated Territory.